Cargando…
Evaluation of the Antiviral Potential of Modified Heterocyclic Base and 5’-Norcarbocyclic Nucleoside Analogs Against SARS-CoV-2
The pandemic caused by the novel betacoronavirus SARS-CoV-2 has already claimed more than 3.5 million lives. Despite the development and use of anti-COVID-19 vaccines, the disease remains a major public health challenge throughout the world. Large-scale screening of the drugs already approved for th...
Autores principales: | Matyugina, E. S., Novikov, M. S., Kozlovskaya, L. I., Volok, V. P., Shustova, E. Y., Ishmukhametov, A. A., Kochetkov, S. N., Khandazhinskaya, A. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A.I. Gordeyev
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807529/ https://www.ncbi.nlm.nih.gov/pubmed/35127150 http://dx.doi.org/10.32607/actanaturae.11479 |
Ejemplares similares
-
Novel 5′-Norcarbocyclic Derivatives of Bicyclic Pyrrolo- and Furano[2,3-d]Pyrimidine Nucleosides
por: Klimenko, Anna A., et al.
Publicado: (2018) -
Investigation of 5’-Norcarbocyclic Nucleoside Analogues as Antiprotozoal and Antibacterial Agents
por: Khandazhinskaya, Anastasia L., et al.
Publicado: (2019) -
Synthesis of New 5′-Norcarbocyclic Aza/Deaza Purine Fleximers - Noncompetitive Inhibitors of E.coli Purine Nucleoside Phosphorylase
por: Khandazhinskaya, Anastasia, et al.
Publicado: (2022) -
New Analogues of Uridine as Possible Anti-Viral Agents Specific to SARS-CoV-2
por: Maslova, A. A., et al.
Publicado: (2022) -
Novel 5′-Norcarbocyclic Pyrimidine Derivatives as Antibacterial Agents
por: Khandazhinskaya, Anastasia L., et al.
Publicado: (2018)